Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Firlik, K. S.
Right arrow Articles by Lunsford, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Firlik, K. S.
Right arrow Articles by Lunsford, L. D.
Related Collections
Right arrow Surgery

Annals of Surgical Oncology, Vol 7, Issue 5 333-338, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Stereotactic radiosurgery for brain metastases from breast cancer

K. S. Firlik, D. Kondziolka, J. C. Flickinger and L. D. Lunsford
Department of Neurological Surgery, University of Pittsburgh Medical Center, Pennsylvania 15213-2582, USA. kfirlik@pop.pitt.edu

BACKGROUND: Stereotactic radiosurgery is an alternative to resection or to radiotherapy alone for patients with brain metastases. Outcomes after radiosurgery for patients with brain metastases specifically from breast cancer have not been defined. METHODS: We retrospectively studied survival and tumor control for all patients with brain metastases from breast cancer who underwent gamma knife stereotactic radiosurgery at the University of Pittsburgh. Univariate and multivariate analyses were used to determine which prognostic factors significantly affected survival. RESULTS: Thirty patients underwent radiosurgery between 1990 and 1997. A total of 58 metastases were treated. The median length of survival for all patients was 13 months from radiosurgery and 18 months from diagnosis of brain metastases. The tumor control rate on follow-up imaging was 93%. On multivariate analysis, the only factor that correlated with longer survival was the absence of multiple brain metastases. Age, presence of systemic disease, previous whole brain radiation, location, and total tumor volume did not significantly affect survival. Four patients had tumors with evidence of radiation-induced edema after radiosurgery but did not require resection. Two patients underwent delayed resection for tumor growth after radiosurgery. CONCLUSIONS: Stereotactic radiosurgery is an effective treatment for brain metastases from breast cancer and is associated with a low complication rate.


This article has been cited by other articles:


Home page
 JCOHome page
N. U. Lin, J. R. Bellon, and E. P. Winer
CNS Metastases in Breast Cancer
J. Clin. Oncol., September 1, 2004; 22(17): 3608 - 3617.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
E. L. Chang and S. Lo
Diagnosis and Management of Central Nervous System Metastases from Breast Cancer
Oncologist, October 1, 2003; 8(5): 398 - 410.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.